Cargando…

Kidney Disease Patient Representation in Trials of Combination Therapy With VEGF-Signaling Pathway Inhibitors and Immune Checkpoint Inhibitors: A Systematic Review

Detalles Bibliográficos
Autores principales: Elyan, Benjamin M.P., Rankin, Stephen, Jones, Rob, Lang, Ninian N., Mark, Patrick B., Lees, Jennifer S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363559/
https://www.ncbi.nlm.nih.gov/pubmed/37492115
http://dx.doi.org/10.1016/j.xkme.2023.100672
_version_ 1785076655286386688
author Elyan, Benjamin M.P.
Rankin, Stephen
Jones, Rob
Lang, Ninian N.
Mark, Patrick B.
Lees, Jennifer S.
author_facet Elyan, Benjamin M.P.
Rankin, Stephen
Jones, Rob
Lang, Ninian N.
Mark, Patrick B.
Lees, Jennifer S.
author_sort Elyan, Benjamin M.P.
collection PubMed
description
format Online
Article
Text
id pubmed-10363559
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103635592023-07-25 Kidney Disease Patient Representation in Trials of Combination Therapy With VEGF-Signaling Pathway Inhibitors and Immune Checkpoint Inhibitors: A Systematic Review Elyan, Benjamin M.P. Rankin, Stephen Jones, Rob Lang, Ninian N. Mark, Patrick B. Lees, Jennifer S. Kidney Med Research Letter Elsevier 2023-05-16 /pmc/articles/PMC10363559/ /pubmed/37492115 http://dx.doi.org/10.1016/j.xkme.2023.100672 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Letter
Elyan, Benjamin M.P.
Rankin, Stephen
Jones, Rob
Lang, Ninian N.
Mark, Patrick B.
Lees, Jennifer S.
Kidney Disease Patient Representation in Trials of Combination Therapy With VEGF-Signaling Pathway Inhibitors and Immune Checkpoint Inhibitors: A Systematic Review
title Kidney Disease Patient Representation in Trials of Combination Therapy With VEGF-Signaling Pathway Inhibitors and Immune Checkpoint Inhibitors: A Systematic Review
title_full Kidney Disease Patient Representation in Trials of Combination Therapy With VEGF-Signaling Pathway Inhibitors and Immune Checkpoint Inhibitors: A Systematic Review
title_fullStr Kidney Disease Patient Representation in Trials of Combination Therapy With VEGF-Signaling Pathway Inhibitors and Immune Checkpoint Inhibitors: A Systematic Review
title_full_unstemmed Kidney Disease Patient Representation in Trials of Combination Therapy With VEGF-Signaling Pathway Inhibitors and Immune Checkpoint Inhibitors: A Systematic Review
title_short Kidney Disease Patient Representation in Trials of Combination Therapy With VEGF-Signaling Pathway Inhibitors and Immune Checkpoint Inhibitors: A Systematic Review
title_sort kidney disease patient representation in trials of combination therapy with vegf-signaling pathway inhibitors and immune checkpoint inhibitors: a systematic review
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363559/
https://www.ncbi.nlm.nih.gov/pubmed/37492115
http://dx.doi.org/10.1016/j.xkme.2023.100672
work_keys_str_mv AT elyanbenjaminmp kidneydiseasepatientrepresentationintrialsofcombinationtherapywithvegfsignalingpathwayinhibitorsandimmunecheckpointinhibitorsasystematicreview
AT rankinstephen kidneydiseasepatientrepresentationintrialsofcombinationtherapywithvegfsignalingpathwayinhibitorsandimmunecheckpointinhibitorsasystematicreview
AT jonesrob kidneydiseasepatientrepresentationintrialsofcombinationtherapywithvegfsignalingpathwayinhibitorsandimmunecheckpointinhibitorsasystematicreview
AT langniniann kidneydiseasepatientrepresentationintrialsofcombinationtherapywithvegfsignalingpathwayinhibitorsandimmunecheckpointinhibitorsasystematicreview
AT markpatrickb kidneydiseasepatientrepresentationintrialsofcombinationtherapywithvegfsignalingpathwayinhibitorsandimmunecheckpointinhibitorsasystematicreview
AT leesjennifers kidneydiseasepatientrepresentationintrialsofcombinationtherapywithvegfsignalingpathwayinhibitorsandimmunecheckpointinhibitorsasystematicreview